MoneyWorks4Me

Glaxosmithkline Pharmaceuticals board to consider unaudited financial results

17 Jul 2024 Evaluate
Glaxosmithkline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Friday, 2nd August 2024, to consider and approval of Un-audited financial results for the quarter ended 30th June 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..